Chronic Wound Clinical Trial
Official title:
Bioglass Wound Dressing in Treatment of Chronic Wound in Different Stage:a Randomized Controlled Trial
Verified date | July 2023 |
Source | Peking University Third Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this randomized control trial is to test the efficacy and safety of a bioglass wound dressing in patients with chronic wound in different stages. The main question it aims to answer are: - Whether the bioglass wound dressing have better efficacy and safety than blank control in treatment of chronic wound in necrosis stable stage? - Whether the bioglass wound dressing have better efficacy and safety than blank control in treatment of chronic wound in granulation growth stage? Participants will be assigned with a 1:1 ratio into intervention group and control group. Participants of intervention group will receive bioglass wound dressing in addition with clinical optimal treatment plan. Participants of control group will only receive clinical optimal treatment plan.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | April 30, 2025 |
Est. primary completion date | May 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. The patient is aged 18-80 years old; 2. Ulcerative wounds; 3. In the stage of stable necrosis or granulation growth; 4. Voluntarily participate in this study and sign an informed consent form Exclusion Criteria: 1. Severe diseases such as acute myocardial infarction, heart failure, hepatitis, shock, and respiratory failure have not been corrected yet; 2. Uncontrolled blood glucose, Glucose test#Fasting blood sugar>15mmol/L, Glycated hemoglobin>12%; 3. There is active bleeding inside the wound, and routine basic treatment plans cannot be implemented; 4. Serum albumin < 20 g/L; Hemoglobin<60 g/L; Platelets<50 × 10^9/L; 5. Spreading infection status, currently or about to be treated with antibiotics; 6. Patients with advanced malignant tumors; 7. Active period of autoimmune diseases; 8. Previous allergies to bioactive glass ointment dressings (self originating); 9. The patient is unable to cooperate or has mental disorders; 10. According to the judgment of the researcher, the subject has a clear reason that cannot be removed and affects wound healing, which is not suitable for this study or cannot comply with the requirements of this study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Peking University Third Hospital | Yunfeng Li |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 2-week reduction rate of wound area | 2-week | ||
Secondary | 2-week wound healing rate | 2-week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05076578 -
A Prospective Clinical Study Evaluating the Harvesting of Micografts
|
N/A | |
Recruiting |
NCT04887688 -
Exciflex for Chronic Wound Therapy
|
N/A | |
Terminated |
NCT03738579 -
Evaluating Wound Healing With Next Science Gel & Wash.
|
N/A | |
Enrolling by invitation |
NCT06444035 -
Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome
|
N/A | |
Completed |
NCT02417779 -
Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy
|
N/A | |
Completed |
NCT02417805 -
Cutaneous Microcirculation After Remote Ischemic Preconditioning
|
N/A | |
Completed |
NCT02417818 -
Cutaneous Microcirculation After Plasma Therapy
|
N/A | |
Completed |
NCT03662997 -
Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds
|
N/A | |
Not yet recruiting |
NCT04132635 -
A Trial to Evaluate the Combination Efficacy of Artificial Dermis and Growth Factor in Chronic Wounds Ulcer
|
N/A | |
Withdrawn |
NCT01646502 -
Treatment of Chronic Wound Biofilms
|
N/A | |
Recruiting |
NCT05342740 -
Study of Biomarkers in Diabetic Chronic Wounds
|
||
Suspended |
NCT02577120 -
Wound Healing Endpoint and Recurrence
|
Phase 4 | |
Recruiting |
NCT06185465 -
Effectiveness and Safety of Using Prontosan to Treat Bacterial Biofilm
|
N/A | |
Completed |
NCT04514783 -
Healthy Tissue Preservation During Wound Debridement by Using Debritom+ Micro Water Jet Technology
|
N/A | |
Terminated |
NCT01429519 -
Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds
|
Phase 1/Phase 2 | |
Recruiting |
NCT05414916 -
Pain Relief Strategies for Dressing Change in Chronic Wounds
|
||
Recruiting |
NCT04019639 -
Efficacy of Paste Type Acellular Dermal Matrix(CG Paste) in Chronic Wound Healing
|
N/A | |
Completed |
NCT05810649 -
Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds
|
N/A |